2024.11.27本文字数:655,阅读时长大约2分钟导读:在小核酸治疗领域,Arrowhead Pharmaceuticals与Sarepta Therapeutics达成的合作协议不仅覆盖了5款临床阶段和2款临床前管线,还可能涉及多达6个靶点的药物开发,总合作金额可能超过100亿美元。2024年11月26日,Arrowhead Pharmaceuticals与Sarepta ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.